Metraipolis › archive › dc_040dd9dc3deb

Concordance between amyloid PET and CSF biomarkers in clinical setting: a cross-platform comparison and in-depth analysis of discordant cases — Europe PMC PMID:41238774

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41238774
DOI: 10.1038/s41598-[numero omesso]-5
License (as archived): solo-consultazione
Archived: 2026-11-08T13:42:14.492Z
SHA-256 of the archived text: 98d57387bb74c70612d02c13e12638663ee122092a6f7507a590524f034f414a
Stable URL of this page: https://metraipolis.com/documento/dc_040dd9dc3deb

How to cite

Concordance between amyloid PET and CSF biomarkers in clinical setting: a cross-platform comparison and in-depth analysis of discordant cases — Europe PMC PMID:41238774 — Europe PMC (en), https://europepmc.org/article/MED/41238774 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_040dd9dc3deb (Metraipolis archive dc_040dd9dc3deb, sha256 98d57387bb74c70612d02c13e12638663ee122092a6f7507a590524f034f414a)

BibTeX

@misc{dc040dd9dc3deb,
  title = {Concordance between amyloid PET and CSF biomarkers in clinical setting: a cross-platform comparison and in-depth analysis of discordant cases — Europe PMC PMID:41238774},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41238774},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_040dd9dc3deb; sha256 98d57387bb74c70612d02c13e12638663ee122092a6f7507a590524f034f414a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41238774. Agents can read the archived copy with the MCP tool read_document.